This content is created by Smallcaps Authors. [Author : Imelda Cotton]
Clinical-stage cell therapy company Chimeric Therapeutics (ASX: CHM) has received commitments from its board and management team to raise $1.04 million under a placement of new shares. The company will issue 22.66 million new and fully-paid ordinary shares at $0.046 each, which is equal to the last closing price on 12 May. The placement will […]
The post Chimeric Therapeutics board and management commit to capital injection appeared first on Small Caps.
from Small Caps https://ift.tt/7SLoAIn
إرسال تعليق